| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.0024 | 1 |